c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways and drive metastatic progression

An EGFR-Src-Arg-Cortactin Pathway Mediates Functional Maturation of Invadopodia and Breast Cancer Cell Invasion

(2011) C. C. Mader et al.   CANCER RESEARCH

c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3

(2010) X Li et al.   CELL DEATH AND DIFFERENTIATION

The Cain and Abl of Epithelial-Mesenchymal Transition and Transforming Growth Factor-β in Mammary Epithelial Cells

(2010) Tressa M. Allington et al.   CELLS TISSUES ORGANS

Abl Kinases Are Required for Invadopodia Formation and Chemokine-induced Invasion

(2010) Pameeka S. Smith-Pearson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Advances in treatment of chronic myelogenous leukemia – new treatment options with tyrosine kinase inhibitors

(2010) Fabio P. S. Santos et al.   LEUKEMIA & LYMPHOMA

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma

(2010) Cynthia Shepherd et al.   Current Oncology Reports

Nanoneoadjuvant Therapy of Gastrointestinal Stromal Tumor (GIST)

(2009) Ronald P. DeMatteo   ANNALS OF SURGICAL ONCOLOGY

Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models

(2009) Miriam Fanjul-Fernández et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy

(2009) K. S.M. Smalley et al.   CANCER RESEARCH

Reciprocal regulation of Abl and receptor tyrosine kinases

(2009) Divyamani Srinivasan et al.   CELLULAR SIGNALLING

Treatment for metastatic malignant melanoma: Old drugs and new strategies

(2009) Roger Mouawad et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Melanoma Epidemiology and Public Health

(2009) Marianne Berwick et al.   DERMATOLOGIC CLINICS

Anal Mucosal Melanoma withKIT-Activating Mutation and Response to Imatinib Therapy – Case Report and Review of the Literature

(2009) Imke Satzger et al.   DERMATOLOGY

Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors

(2009) Tressa M. Allington et al.   FASEB JOURNAL

A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis

(2009) J S Blackburn et al.   ONCOGENE

Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells

(2008) Audrey Sirvent et al.   BIOLOGY OF THE CELL

Nilotinib

(2008) M. W. Deininger   CLINICAL CANCER RESEARCH

Overexpression of the KIT/SCF in Uveal Melanoma Does Not Translate into Clinical Efficacy of Imatinib Mesylate

(2008) U. B. Hofmann et al.   CLINICAL CANCER RESEARCH

Abl Kinases Regulate Autophagy by Promoting the Trafficking and Function of Lysosomal Components

(2008) Gouri Yogalingam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate

(2008) Youichi Ogawa et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Activated c-Abl tyrosine kinase in malignant solid tumors

(2008) J Lin et al.   ONCOGENE